MBX Biosciences, Inc. - 8-K Filing
MBX Biosciences stockholders approved the election of two Class II directors—Patrick J. Heron and Edward T. Mathers—for three-year terms ending in 2029 at their June 4, 2026 annual meeting. Withholding votes were 4,579,129 for Heron and 7,603,529 for Mathers out of a total of 47,570,485 shares outstanding as of April 10, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 below, the Company's stockholders approved the election of two Class II directors to serve for a three-year term ending at the annual meeting)
Tickers: $MBX